‘Science Speaks’ Reports On TB-Related Study Results Presented At 47th Union World Conference On Lung Health

Center for Global Health Policy’s “Science Speaks”: 47th Union World Conference on Lung Health: Regimen simplifies treatment for patients with tuberculosis — including drug-resistant disease, researchers say
Antigone Barton, senior editor and writer of “Science Speaks,” reports on study results presented at the 47th Union World Conference on Lung Health showing an experimental combination of four drugs cured TB patients faster than standard treatment regimens (10/28).

Center for Global Health Policy’s “Science Speaks”: 47th Union World Conference on Lung Health: Early data indicates new regimen represents reprieve for patients with XDR-TB
Barton discusses study results presented at the conference showing an experimental drug regimen using three drugs was able to cure extensively drug-resistant tuberculosis, or XDR-TB, among patients who completed the therapy (10/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.